MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.

M.J. van den Bent; L. Erdem-Eraslan; A. Idbaih; J. de Rooi; P.H.C. Eilers; W.G.M. Spliet; W.F den Dunnen; C. Tijssen; P. Wesseling; P.A. Sillevis Smitt; J.M. Kros; T Gorlia; P.J. French

MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.

Translated title of the contribution: MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.

M.J. van den Bent, L. Erdem-Eraslan, A. Idbaih, J. de Rooi, P.H.C. Eilers, W.G.M. Spliet, W.F den Dunnen, C. Tijssen, P. Wesseling, P.A. Sillevis Smitt, J.M. Kros, T Gorlia, P.J. French

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.
Original language	Undefined/Unknown
Pages (from-to)	5513-5522
Number of pages	10
Journal	Clinical Cancer Research
Volume	19
Issue number	19
Publication status	Published - 2013

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/23948976

Cite this

van den Bent, M. J., Erdem-Eraslan, L., Idbaih, A., de Rooi, J., Eilers, P. H. C., Spliet, W. G. M., den Dunnen, W. F., Tijssen, C., Wesseling, P., Sillevis Smitt, P. A., Kros, J. M., Gorlia, T., & French, P. J. (2013). MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951. Clinical Cancer Research, 19(19), 5513-5522. http://www.ncbi.nlm.nih.gov/pubmed/23948976

@article{1525f78df15e42f18dc68ef9f0faae7a,

title = "MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.",

author = "{van den Bent}, M.J. and L. Erdem-Eraslan and A. Idbaih and {de Rooi}, J. and P.H.C. Eilers and W.G.M. Spliet and {den Dunnen}, W.F and C. Tijssen and P. Wesseling and {Sillevis Smitt}, P.A. and J.M. Kros and T Gorlia and P.J. French",

year = "2013",

language = "Undefined/Unknown",

volume = "19",

pages = "5513--5522",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "19",

}

van den Bent, MJ, Erdem-Eraslan, L, Idbaih, A, de Rooi, J, Eilers, PHC, Spliet, WGM, den Dunnen, WF, Tijssen, C, Wesseling, P, Sillevis Smitt, PA, Kros, JM, Gorlia, T & French, PJ 2013, 'MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.', Clinical Cancer Research, vol. 19, no. 19, pp. 5513-5522. <http://www.ncbi.nlm.nih.gov/pubmed/23948976>

TY - JOUR

T1 - MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.

AU - van den Bent, M.J.

AU - Erdem-Eraslan, L.

AU - Idbaih, A.

AU - de Rooi, J.

AU - Eilers, P.H.C.

AU - Spliet, W.G.M.

AU - den Dunnen, W.F

AU - Tijssen, C.

AU - Wesseling, P.

AU - Sillevis Smitt, P.A.

AU - Kros, J.M.

AU - Gorlia, T

AU - French, P.J.

PY - 2013

Y1 - 2013

M3 - Article

SN - 1078-0432

VL - 19

SP - 5513

EP - 5522

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 19

ER -